Australia's largest stock trading and investment forum Australia's #1 stock forum

MND

2.82%

$12.76 monadelphous group limited

Great comments.

First 61 Last

Share
Profile

Follow
MarsC

4,287 Posts.

467

22/06/16

13:28

Post #: 18093248
Share

Originally posted by croasian ↑

I think it's a case of do as I say not as I do. He was on the board of many companies and very much an activist investor pushing for change and passionate about the interests of the small holder.
He could have taken his cash out of Geico as he controlled it, the importance of control is huge.
His thinking changed over his lifetime.
When he wrote securities analysis in the 1930's he put much stock in deeply analysing the prospects of companies but later in life when he wrote the intelligent investor he believed that it was impossible to pick future prospects at all.
Inasmuch as the future is known its priced into analyst expectations but very little is known for certain.
Pretty Zen.
His approach there was to buy a vastly diversified portfolio purely on the numbers as you say. There's a lot to be said for this.
I can't do this now as the market is too hot. Bond yields are awful a hard time for investors all around.
I don't follow what he said exactly, it's a great starting point but I have my own ideas. It's important to understand that he lost money during the great depression, the experience led to the margin of safety concepts.
I think he was over engineering things by adding excessive diversification though. If you buy a company for say 30% of what it is worth and you have a really good idea of what it is worth you are not immune to adverse unexpected outcomes but it is very unlikely that they will reduce the value of your business below what you paid.
Then you diversify but how much? Depends how confident you are 4 big holdings and wide diversification just on the numbers?
Seems like a good plan for me, that will be my way. Not one size fits all though.

Expand

Great comments.

MND Price at posting: $7.88 Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

First 61 Last

Add MND (ASX) to my watchlist

(20min delay)
Last $12.76		Change -0.370(2.82%)		Mkt cap ! $1.255B

Open	High	Low	Value	Volume
$13.01	$13.14	$12.75	$3.021M	235.3K

Buyers (Bids)

No.	Vol.	Price($)
1	754	$12.75

Sellers (Offers)

Price($)	Vol.	No.
$12.84	843	1

View Market Depth

No.	Vol.	Price($)
1	754	12.750
2	843	12.730
2	2730	12.720
2	1843	12.710
1	843	12.690

Price($)	Vol.	No.
12.840	843	1
12.860	843	1
12.870	843	1
12.890	843	1
13.080	6985	2

Last trade - 16.10pm 04/10/2024 (20 minute delay)

MND (ASX) Chart

Great comments.

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Great comments.

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News